Clinical trials
Phase 3 Diabetic Neuropathies trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Chromaderm, Inc. | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Sumitomo Pharma Co., Ltd. | 1 |
| The Canadian College of Naturopathic Medicine | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Neuropathies | 7 |
| Neuralgia | 2 |
| Agnosia | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Pain | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.